Vanguard Capital Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$45M Buy
3,395,553
+499,549
+17% +$6.32M ﹤0.01% 1946
2026
Q2
$32.1M Buy
2,896,004
+136,884
+5% +$837K ﹤0.01% 2170
2026
Q1
$21.1M Buy
+2,759,120
New +$21.1M ﹤0.01% 2311

Other funds holding REPL

Vanguard Capital Management's REPL Position: Q3 2026 in Review

Vanguard Capital Management increased its Replimune Group (REPL) stake by 17% in Q3 2026, buying an estimated $6.32M and bringing the position to 3,395,553 shares worth $45M. The position accounts for ﹤0.01% of the portfolio, ranked #1946.

Vanguard Capital Management first reported a position in REPL in Q1 2026 and has held it in 3 quarters since. 208 funds tracked by Wall St. Rank hold REPL as of Q3 2026.

  • Vanguard Capital Management held 3,395,553 shares of Replimune Group worth $45M as of Q3 2026.
  • Vanguard Capital Management bought 499,549 Replimune Group shares in Q3 2026, an estimated $6.32M.
  • Replimune Group made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1946 holding.
  • Vanguard Capital Management first reported a position in Replimune Group in Q1 2026 and has held it in 3 quarters since.
  • 208 funds tracked by Wall St. Rank held Replimune Group as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.